We have since initiated over 15 discovery projects since the inception of Regor in June 2018. Our projects cover oncology, autoimmune and metabolic diseases areas with a strategy balance of Best-In-Class and First-In-Class programs. By fully leveraging our CARD technology platform, we are able to deliver four PCCs within the range of 10-12 months from the initiation of each program.

245 Main Street, Second Floor, Cambridge, MA 02142, USA
1206 Zhangjiang Rd, Building C, Pudong New District, Shanghai 201210, China